Merck Emerging-Market Plans Lead To Cuts In Developed-Market Staff
This article was originally published in PharmAsia News
Executive Summary
Merck's plans for China, Brazil and Russia have led the U.S.-based company to trim its sales forces in developed markets by 32 percent this year